statistiche ricercatore

Nazione	#
US - Stati Uniti d'America	303
SG - Singapore	133
BR - Brasile	65
CN - Cina	62
VN - Vietnam	36
HK - Hong Kong	27
IN - India	17
FI - Finlandia	14
IT - Italia	14
GB - Regno Unito	10
AR - Argentina	9
FR - Francia	7
CA - Canada	6
DE - Germania	6
BD - Bangladesh	5
IE - Irlanda	5
MX - Messico	4
CL - Cile	3
CO - Colombia	3
DO - Repubblica Dominicana	3
ID - Indonesia	3
IQ - Iraq	3
RU - Federazione Russa	3
UA - Ucraina	3
AE - Emirati Arabi Uniti	2
BE - Belgio	2
EC - Ecuador	2
JP - Giappone	2
KG - Kirghizistan	2
LT - Lituania	2
NL - Olanda	2
PE - Perù	2
PL - Polonia	2
SE - Svezia	2
ZA - Sudafrica	2
AZ - Azerbaigian	1
BY - Bielorussia	1
CG - Congo	1
EG - Egitto	1
GR - Grecia	1
JM - Giamaica	1
JO - Giordania	1
LA - Repubblica Popolare Democratica del Laos	1
LK - Sri Lanka	1
MA - Marocco	1
MN - Mongolia	1
MY - Malesia	1
NP - Nepal	1
NR - Nauru	1
PH - Filippine	1
PK - Pakistan	1
PR - Porto Rico	1
PY - Paraguay	1
SA - Arabia Saudita	1
SI - Slovenia	1
SN - Senegal	1
SV - El Salvador	1
SY - Repubblica araba siriana	1
TN - Tunisia	1
UY - Uruguay	1
VE - Venezuela	1
Totale	792

Nome	#
A 'Multiomic' Approach of Saliva Metabolomics, Microbiota, and Serum Biomarkers to Assess the Need of Hospitalization in Coronavirus Disease 2019	129
Malignant mesothelioma-associated inflammatory microenvironment promotes tumor progression via GPNMB	82
Intratumoral combination therapy with poly(I:C) and resiquimod synergistically triggers tumor-associated macrophages for effective systemic antitumoral immunity	76
The soluble glycoprotein NMB (GPNMB) produced by macrophages induces cancer stemness and metastasis via CD44 and IL-33	73
Inhibition of tumor-associated macrophages by trabectedin improves the antitumor adaptive immunity in response to anti-PD-1 therapy	71
Optimization of a Luciferase-Expressing Non-Invasive Intrapleural Model of Malignant Mesothelioma in Immunocompetent Mice	70
Tumor-Associated Macrophages: toward a better understanding of their cancer driver capability in Malignant Pleural Mesothelioma	59
Effects of the Anti-Tumor Agents Trabectedin and Lurbinectedin on Immune Cells of the Tumor Microenvironment	59
The Dark Side of the Force: When the Immune System Is the Fuel of Tumor Onset	48
Important functional role of the protein osteopontin in the progression of malignant pleural mesothelioma	47
Macrophages and cancer stem cells: a malevolent alliance	46
Targeting Tumor-Associated Macrophages in Anti-Cancer Therapies: Convincing the Traitors to Do the Right Thing	41
Totale	801

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2021/2022	10	0	0	0	0	0	0	0	0	0	0	0	10
2022/2023	32	6	0	4	1	3	2	0	3	4	4	5	0
2023/2024	58	5	5	8	3	2	12	9	2	1	0	5	6
2024/2025	175	1	0	3	2	8	33	8	10	23	47	19	21
2025/2026	526	58	73	54	38	12	34	97	44	31	46	28	11
Totale													801